Getting at MYC through RAS. [Clin Cancer Res. 2005] - PubMed

loading

Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. [Clin Cancer Res. 2005]
Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, Kloog Y. Clin Cancer Res. 2005 Jun 15; 11(12):4321-30.
Ras inhibits endoplasmic reticulum stress in human cancer cells with amplified Myc. [Int J Cancer. 2010]
Ras inhibits endoplasmic reticulum stress in human cancer cells with amplified Myc.
Yaari-Stark S, Shaked M, Nevo-Caspi Y, Jacob-Hircsh J, Shamir R, Rechavi G, Kloog Y. Int J Cancer. 2010 May 15; 126(10):2268-81.
Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas. [Mol Cancer Ther. 2010]
Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
Levy R, Grafi-Cohen M, Kraiem Z, Kloog Y. Mol Cancer Ther. 2010 Aug; 9(8):2208-19. Epub 2010 Aug 3.
Review c-Myc: linking transformation and genomic instability. [Curr Mol Med. 2008]
Review c-Myc: linking transformation and genomic instability.
Prochownik EV. Curr Mol Med. 2008 Sep; 8(6):446-58.
Review Control of cell proliferation and growth by Myc proteins. [Results Probl Cell Differ. 2006]
Review Control of cell proliferation and growth by Myc proteins.
Bernard S, Eilers M. Results Probl Cell Differ. 2006; 42:329-42.

Review Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies? [Endocr Pathol. 2012]
Review Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?
Korpershoek E, Pacak K, Martiniova L. Endocr Pathol. 2012 Mar; 23(1):43-54.
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals. [Mol Cancer Ther. 2011]
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals.
Marampon F, Gravina GL, Di Rocco A, Bonfili P, Di Staso M, Fardella C, Polidoro L, Ciccarelli C, Festuccia C, Popov VM, et al. Mol Cancer Ther. 2011 Jan; 10(1):159-68.
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. [PLoS One. 2008]
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
Tran PT, Fan AC, Bendapudi PK, Koh S, Komatsubara K, Chen J, Horng G, Bellovin DI, Giuriato S, Wang CS, et al. PLoS One. 2008 May 7; 3(5):e2125. Epub 2008 May 7.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Getting at MYC through RAS.
Getting at MYC through RAS.
Clin Cancer Res. 2005 Jun 15 ;11(12):4278-81.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed